glp-1 drugs medications get at the heart of addiction: study – WashU Medicine America's Poison Centers - GLP-1
Description
It can change mid-year in some cases, though insurers typically must provide 60 days notice before removing a medication
Tirzepatide raised the bar to ~20%
This treatment option is especially beneficial for individuals with prediabetes, insulin resistance, or metabolic syndrome
2025;48(Supplement_1):S20738
Kappe et al., 2012)
However, quantitative comparisons of the efficacy of these GLP-1 receptor agonist drugs in obesity treatment, particularly between mono-, dual-, and triple-agonists, are still lacking
